Company / Return on Assets (ROA)
Cue Biopharma, Inc. Return on Assets (ROA) History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-63.0%
FY2025
5-year range
-126.4% / -52.9%
FY2021-FY2025
Trend
+50.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Assets (ROA) returned to growth in FY2025 after 4 years of decline, reaching -63.0%.
Based on SEC 10-K filings.
-63.0% in FY2025 with a 5-year CAGR of -26.1%.
Improved from -82.5% to -63.0% over the past 2 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -4.9pp
- 5-Year Change
- -26.1pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, return on assets (roa) increased 50.1% year-over-year.
- Peak return on assets (roa) was recorded in FY2020.
- Lowest return on assets (roa) in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -7.60 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -63.0% | +50.1% |
| FY2024 | -126.4% | -53.2% |
| FY2023 | -82.5% | -42.0% |
| FY2022 | -58.1% | -9.7% |
| FY2021 | -52.9% | -43.6% |
| FY2020 | -36.9% | +32.3% |
| FY2019 | -54.4% | -6.3% |
| FY2018 | -51.2% | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026